Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe R Anderson

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Cardiology in Review|June 20, 2008
Glycoprotein IIb/IIIa inhibitors in patients with renal insufficiency undergoing percutaneous coronary interventionJoe R Anderson, Dan Riding
Cardiology in Review|August 10, 2012
Statin loading before percutaneous coronary intervention to reduce periprocedural myocardial infarctionDavena M Norris, Joe R Anderson
Cardiology in Review|June 14, 2005
Ranolazine. A metabolic modulator for the treatment of chronic stable anginaJoe R Anderson, James J Nawarskas
Patient Preference and Adherence|May 16, 2013
Ambrisentan for the treatment of pulmonary arterial hypertension: improving outcomesSoha M Elshaboury, Joe R Anderson
Heart Disease (Hagerstown, Md.)|July 31, 2002
Levosimendan: a unique approach to the treatment of heart failureJames J Nawarskas, Joe R Anderson
Cardiology in Review|December 19, 2006
BiDil (isosorbide dinitrate and hydralazine): a new fixed-dose combination of two older medications for the treatment of heart failure in black patientsMelinda S Carmody, Joe R Anderson
Cardiology in Review|April 17, 2010
Pharmacotherapeutic management of pulmonary arterial hypertensionJoe R Anderson, James J Nawarskas
Heart Disease (Hagerstown, Md.)|November 25, 2003
Ximelagatran: a new oral anticoagulantLenka Hrebickova, James J Nawarskas, Joe R Anderson
Journal of General Internal Medicine|December 14, 2011
Blood pressure monitoring technique impacts hypertension treatmentGretchen M Ray, James J Nawarskas, Joe R Anderson
Cardiology in Review|April 4, 2015
Ivabradine: A Unique and Intriguing Medication for Treating Cardiovascular DiseaseJames J Nawarskas, Brandi N Bowman, Joe R Anderson
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Cardiology in Review|June 20, 2008
Glycoprotein IIb/IIIa inhibitors in patients with renal insufficiency undergoing percutaneous coronary interventionJoe R Anderson, Dan Riding
Cardiology in Review|August 10, 2012
Statin loading before percutaneous coronary intervention to reduce periprocedural myocardial infarctionDavena M Norris, Joe R Anderson
Cardiology in Review|June 14, 2005
Ranolazine. A metabolic modulator for the treatment of chronic stable anginaJoe R Anderson, James J Nawarskas
Patient Preference and Adherence|May 16, 2013
Ambrisentan for the treatment of pulmonary arterial hypertension: improving outcomesSoha M Elshaboury, Joe R Anderson
Heart Disease (Hagerstown, Md.)|July 31, 2002
Levosimendan: a unique approach to the treatment of heart failureJames J Nawarskas, Joe R Anderson
Cardiology in Review|December 19, 2006
BiDil (isosorbide dinitrate and hydralazine): a new fixed-dose combination of two older medications for the treatment of heart failure in black patientsMelinda S Carmody, Joe R Anderson
Cardiology in Review|April 17, 2010
Pharmacotherapeutic management of pulmonary arterial hypertensionJoe R Anderson, James J Nawarskas
Heart Disease (Hagerstown, Md.)|November 25, 2003
Ximelagatran: a new oral anticoagulantLenka Hrebickova, James J Nawarskas, Joe R Anderson
Journal of General Internal Medicine|December 14, 2011
Blood pressure monitoring technique impacts hypertension treatmentGretchen M Ray, James J Nawarskas, Joe R Anderson
Cardiology in Review|April 4, 2015
Ivabradine: A Unique and Intriguing Medication for Treating Cardiovascular DiseaseJames J Nawarskas, Brandi N Bowman, Joe R Anderson
Pageof 4